This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07168/identifier/pdb/
n11http://bio2rdf.org/drugbank:
n4http://linked.opendata.cz/resource/drugbank/drug/DB07168/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07168/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07168/identifier/drugbank/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n5http://linked.opendata.cz/resource/drugbank/drug/DB07168/identifier/chemspider/

Statements

Subject Item
n2:DB07168
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n10:DB07168 n11:DB07168
dcterms:title
[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile
adms:identifier
n4:23624249 n5:22376329 n6:DB07168 n12:99443639 n14:5CP
n7:IUPAC-Name
n8:271B5099-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B509F-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B509E-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B509B-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B509C-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B509D-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B5097-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B5095-363D-11E5-9242-09173F13E4C5 n8:271B5098-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B5096-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B50A5-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B50A6-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B50A0-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B50A1-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B50A3-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B50A2-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B50A4-363D-11E5-9242-09173F13E4C5
n7:Bioavailability
n8:271B50AB-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B50AD-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B50AE-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B50AA-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B50A9-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B50AC-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B509A-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B50A7-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B50A8-363D-11E5-9242-09173F13E4C5